See also this year's filing and all EDGAR filings for this company.
PDF Report 0001708599_2023_AgeX_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001708599, AgeX Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,453,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 738,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 50,000 |
| 4 | LiabilitiesCurrent | 10,078,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 10,478,000 |
| 7 | CostOfGoodsAndServicesSold | 13,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,971,000 |
| 9 | ResearchAndDevelopmentExpense | 1,025,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 34,000 |
| 12 | remainder_NetIncome | -3,547,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,241,000 |
| 1 | Liabilities | 20,556,000 |
| 2 | Expenses | 7,009,000 |
| 3 | Revenues | 34,000 |
| 4 | StockholdersEquity | -17,315,000 |
| 5 | NetIncome | -10,522,000 |
| 6 | ComprehensiveNetIncome | -10,522,000 |
| 7 | BaseVar | 17,193,500 |
| 8 | EconomicCapitalRatio | -3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
